Brief: Centogene Appoints Patrice P. Denèfle As Chief Scientific Officer To Lead Its Data-Driven Approach To Reinvent Rare Disease Drug Discovery And Development
27/07/2021 11:39
July 27 (Reuters) - Centogene NV 39K.MU :
* CENTOGENE APPOINTS PATRICE P. DENÈFLE AS CHIEF SCIENTIFIC
OFFICER TO LEAD ITS DATA-DRIVEN APPROACH TO REINVENT RARE
DISEASE DRUG DISCOVERY AND DEVELOPMENT
Source text for Eikon: ID:nGNX9nT852
Further company coverage: 39K.MU
Recent news on Crown LiquidationCo NV in liquidatie
See all newsBrief: Centogene Signs Strategic Transaction With Private Equity Group Charme Capital Partners
Brief: Centogene Announces Adoption Of All Resolutions Tabled At 2024 Annual General Meeting
Brief: Centogene NV Says Agreements With LIFERA Provides Funding In Aggregate Of About $20 Mln To Co
Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease
Brief: Centogene Receives Nasdaq Non-Compliance Notice